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Abstract
 Flavonoid has potential bioactivity as anticancer agents. The flavonoid of cultivated 
tobacco (Nicotiana tabacum), locally known as “Kasturi”, leaves was screened for its 
cytotoxicity against MCF-7 human breast cancer cells and non-transformed Vero cells 
(African normal cell kidney line) in different concentrations. This study aimed to examine 
the cytotoxic potential of the flavonoid of Kasturi tobacco leaves against MCF-7 human 
breast cancer cells. Flavonoid obtained from methanolic extracts of Kasturi tobacco 
leaves, which have been purified from nicotine. The flavonoid of Kasturi tobacco leaves 
with concentrations of 20 to 640 μg/mL were exposed to MCF-7 and Vero cells for 24 h. 
Cell viability was evaluated by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium 
bromide (MTT) assay. Flavonoid of Kasturi tobacco leaves with concentrations of 160 μg/mL 
decreased the MCF-7 cell viability more than 50%, with an inhibitory concentration 50 (IC50) 
value of 148.41 μg/mL. Meanwhile, it inhibited 50% of Vero cell viability at 255.35 μg/mL. 
The flavonoid of Kasturi tobacco leaves has cytotoxic activity on MCF-7 cells, and might be 
a potential alternative agent for human breast cancer therapy.  
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INTRODUCTION
 Cultivated tobacco, locally known as 
Kasturi tobacco, (Nicotiana tabacum) is local 
tobacco Voor Oogst, which is planted in Jember and 
Bondowoso areas. Kasturi tobacco is intended as 
raw material for domestic cigarettes, which reaches 
88.64% and around 11.36% is exported. In addition 
to extensive use of cigarette products, tobacco 
leaves are a rich source of many biologically 
active substances with pharmacological properties. 
Many researchers have made efforts to diversify 
tobacco products, starting with determination of 
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total phenolic and total flavonoid from tobacco 
leaves (Fathiazad, et al., 2006; Xie, et al., 2011; 
Karabegović, et al., 2011), and analysis the 
antioxidant activity of purified flavonoid from 
nicotine and phenolic acid (Docheva, et al., 2014). 
On the other hand, it is known that flavonoid have 
various anticancer phytochemicals with potential 
bioactivity that can reduce cancer susceptibility, 
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and can be candidates for cancer prevention (Yang, 
et al., 2001; Le Marchand, 2002).
 Breast cancer is the second most common 
malignant tumor in the world and causes cancer-
related deaths after lung cancer. Unfortunately, 
the overall response rate of cancer treatment is 
unsatisfactory because of the late diagnosis and 
efficacy of poor treatment, especially resistance 
to chemotherapy drugs and metastasis to other 
organs (Metwaly, et al., 2012). In addition, many 
chemotherapy drugs reduce the therapeutic effect 
due to drug resistance problems (Peters, et al., 2002). 
Chemotherapy drugs also cause toxicity to normal 
cell, and unpleasant side effects for patients. For this 
reason, it takes research and development of a new 
class of anticancer agents that have selective and 
efficient toxicity in cells. Among various sources 
of anticancer drugs, the use of natural resources 
from plants has many benefits about the potential 
to produce a variety of anticancer agents. In this 
study, we aimed to find a new source of natural 
anticancer isolated from Kasturi tobacco leaves and 
investigate the cytotoxicity ability of the flavonoid 
of Kasturi tobacco leaves against MCF-7 and Vero 
cells. 
MATERIALS AND METHODS
Kasturi tobacco Leaves Extraction 
 Dried Kasturi tobacco leaves (50 g) were 
ground and sieved until tobacco leaf powder is 
obtained. Tobacco leaves powder were macerated 3 
times with methanol (Merck, Darmstadt, Germany) 
and stirred for 24 h to bind compounds in tobacco 
leaves (Hossain & Salehuddin, 2013), then were 
filtered using a Buchner funnel. The filtrate was 
fractionated by liquid-liquid extraction using 
ethyl acetate (Merck) (Mujwah, et al., 2010), 
and separated between the methanol and ethyl 
acetate phases with a separating funnel. The ethyl 
acetate phase was added with 10% HCl (Merck) 
to remove the nicotine (alkaloid) content and was 
tested with Dragendorff reagent (ACS Chemicals, 
Gujarat, India). The extract will be yellow if 
it is free of nicotine and will be orange if it still 
contains nicotine. Extract was evaporated using a 
rotary evaporator until a thick extract is obtained. 
The extract was weighed 1.216 g, with a yield of 
2.432%.
Total Phenolic in Kasturi tobacco Leaves 
Extract
 The extract was dissolved with methanol 
(Merck) in a concentration of 1 mg/mL. The 
reaction mixture was made with a composition of 
0.5 mL of extracted methanol solution, 2.5 mL of 
10% Folin-Ciocalteu reagent (Sigma-Aldrich, St. 
Louis, Missouri, USA) that has been dissolved in 
water and 2.5 mL of 7.5% NaHCO3 (Merck). The 
blank was made with a composition of 0.5 mL of 
methanol (Merck), 2.5 mL of 10% Folin-Ciocalteu 
reagent (Sigma-Aldrich) dissolved in water and 
2.5 mL of 7.5% NaHCO3 (Merck). The sample was 
incubated at 45°C for 45 minutes. Absorbance was 
determined using a spectrophotometer at λmax=765 
nm and carried out in triplicate for each analysis. 
The same procedure was repeated for standard 
gallic acid solution (Sigma-Aldrich) as a calibration 
curve (Stanković, 2011). Based on the absorbance 
measured, the phenolic concentration is read (mg/
mL) from the calibration line; then the phenolic 
content in the extract is expressed in the form of 
gallic acid equivalent (mg GA/g extract). The 
phenolic content in Kasturi tobacco leaves extract 
was 0.878 mg/g.
Cell Line and Culture Condition
 Human breast cancer cells (MCF-7) and 
normal African green monkey kidney epithelial 
(Vero) cell lines were maintained at the Laboratory 
of Parasitology, Faculty of Medicine, Universitas 
Gadjah Mada, Indonesia. The cell culture medium 
was Dulbecco’s modified Eagle’s medium (DMEM) 
(Gibco, Canada, USA) supplemented with 10% 
fetal bovine serum (FBS) (Gibco, Brazil, USA), 100 
units/mL penicillin and 100 μg/mL streptomycin 
(Gibco, Germany). The cells were cultured at 37°C 
under a humidified atmosphere containing 5% CO2.
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Cytotoxicity Screening by 3-(4, 5-dimethyl-
2-thiazolyl)-2, 5-diphenyl-2H-tetrazolium 
bromide (MTT) Assay
 Cytotoxicity of flavonoid was determined 
by MTT assay. Briefly, MCF-7 and Vero cells 
were seeded into 96-well plates (5000 cells/well 
in 100 μL of media) and incubated for 24 h. Prior 
to the experiment, the stock solution of flavonoid 
was prepared by dissolving in dimethyl sulfoxide 
(DMSO) (Sigma-Aldrich) and diluted to working 
solutions with media serially to obtain appropriate 
concentrations. The final concentration of DMSO 
(Sigma-Aldrich) in each sample did not exceed 
1% v/v. Cells were treated with the flavonoid at 
concentrations of 20, 40, 80, 160, 320, and 640 
μg/mL and incubated for 24 h. MCF-7 and Vero 
cells in positive control group were treated with 
doxorubicin (Sigma-Aldrich). The medium from 
each well was removed carefully after incubation. 
Two hundred microliters of MTT solution (5 mg/
mL) (Sigma-Aldrich) was added. The plates were 
incubated for 4 h in dark. After incubation, MTT 
solution was removed without disturbing the 
formazan crystals and 100 μL of DMSO (Sigma-
Aldrich) was added to each well and mixed well to 
dissolve the crystals properly. The development of 
purple color due to formation of formazan crystals 
visualized the viable cells. The absorbance was 
measured on microplate reader at 570 nm. The 
inhibitory concentration 50 (IC50) values were 
determined from the graphs of flavonoid on MCF-
7 and Vero cells. The cell viability percentage was 
calculated based on the absorbance ratio between 
cell culture treated with flavonoid and the untreated 
control multiplied by 100% (Wang, et al., 2006). 
Experiment was repeated three times independently, 
and each with triplicate sets of reaction.
Statistical analysis
 The mean values±standard deviation 
of three independent experiments was used for 
quantitative variables. Statistical significance 
was ascertained by one-way ANOVA, followed 
by Tukey’s post hoc test of significance between 
different groups. Statistical significance was 
predefined as P≤0.05. 
RESULTS
 The flavonoid of Kasturi tobacco leave was 
tested to evaluate the cytotoxic potential against the 
human breast cancer cells. The MTT assay showed 
remarkable cytotoxicity against MCF-7 cells in a 
dose dependent manner. The flavonoid started to 
show cytotoxicity on Vero cells at concentrations 
of 320 μg/mL and the calculated IC50 was obtained 
at 255.35 μg/mL. The cell viability count to deter-
mine anticancer activity against MCF-7 and Vero 
cells is represented in Table 1 and Figure 1. The 
anticancer activity of flavonoid against MCF-7 cell 
lines showed higher cytotoxicity at concentrations 
of 160, 320, and 640 μg/mL, with an IC50 of 148.41 
μg/mL. These data suggested that the extracts are 
more toxic to cancer cells than normal cells. Never-
theless, flavonoid was not as active as doxorubicin. 
Doxorubicin with concentration of 0.8 μg/mL can 
decrease cell viability of MCF-7 and Vero cells 
about 65.28±7.20 % and 58.92±6.90 %, respec-
tively.
DISCUSSION
 Cancer chemoprevention by using natural 
ingredients in the form of  dietary  or  synthetic 
substances can reverse, suppress, or prevent car-
cinogenic development. This strategy is very in-
teresting to combat the dogma associated with 
increasing cases of cancer throughout the world 
(Tsao, et al., 2004). Plant extracts that act as anti-
cancer drugs must be able to kill cancer cells with-
out causing excessive damage to normal cells (La-
croix, et al., 2006). Flavonoids are plant pigments 
consisting of natural phytochemical classes, and 
have various biological effects that can play a role 
in cancer prevention and cancer therapy. Increased 
anticancer activity correlates with an increase in the 
number of polyphenolic compounds (Danciu, et al., 
2015). Quercetin, a member of flavonol, is reported 
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Table 1. Effect of flavonoid of Kasturi tobacco leaves on cell viability of MCF-7 and Vero cells by MTT assay.
Concentration 
(µg/mL) 
Cell Viability (%)a 
P Value  
Vero Cell Line   MCF-7 Cell Line 
Flavonoid 640  6.98±2.03   1.54±0.77 0.56 
Flavonoid 320  3 8.26±19.04   2.32±1.54 0.00 
Flavonoid 160  93.52±17.54   39.77±27.27 0.00 
Flavonoid 80  98.92±14.77   96.05±16.30 0.76 
Flavonoid 40  105.33±8.67 101.51±14.90 0.68 
Flavonoid 20  112.18±19.59 93.69±7.91 0.05 
Doxorubicin 0.8  5 8.92±6.90 65.28±7.20 0.50 
as an attractive anticancer agent against breast can-
cer (Brusselmans, et al., 2005; Du, et al., 2010; 
Hashemzaei, et al., 2017). The antioxidant activity 
of quercetin is believed to have a cytoprotective 
role against oxidative stress. Quercetin is not only 
protecting cells from free radical damage through 
antioxidant effects, but also motivates apoptotic 
cell death through pro-oxidant activity and inhibits 
tumorigenesis (Gibellini, et al., 2010).
 MCF-7 cells are estrogen-receptor (ER) 
positive and are classified as low-grade and luminal 
types (Kenny, et al., 2007). Our results showed that 
the flavonoid of Kasturi tobacco leaves has more 
cytotoxic effects on MCF-7 than Vero cells (Table 
1 and Figure 1). These results indicated that our ex-
tract is more selective for breast cancer cells than 
normal cells. Flavonoid of Kasturi tobacco leaves 
aMean±standard deviation of three independent experiments; bnormal cells; ccancer cells. Data were ana-
lyzed using one-way ANOVA and followed by Tukey’s post hoc test (P≤0.05). 
can be considered as potential chemotherapy or 
chemopreventive agent based on its ability to in-
duce apoptosis in cancer cells with relatively low 
toxicity to normal cells. The IC50 value of the fla-
vonoid of Kasturi tobacco leaves (148.41 μg/mL) 
was found to be more efficient for anti-breast can-
cer cell activity. Therefore, anticancer strength may 
be related to quercetin content in our extract, which 
quercetin can induce cytotoxicity in the cancer cell 
line through various routes of action. Quercetin can 
induce DNA damage, which needs to be repaired 
before  cell  division  occurs, and induces cytotox-
icity by activating the intrinsic pathway of apop-
tosis (Srivastava, et al., 2016). This confirms our 
assumption that the flavonoid can be responsible for 
the anticancer activity of Kasturi tobacco leaves.
Figure 1. Cytotoxic potential of flavonoid from Kasturi tobacco leaves on MCF-7 and Vero cells. Error bar 
represents mean±standard deviation of experiments performed in three repetitions.
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CONCLUSION
 Viability of breast cancer cells will decrease 
according to dependent-dose. The flavonoid of Kas-
turi tobacco leaves proved to be able to reduce 50% 
viability of breast cancer cells at a concentration of 
148.41 μg/mL. The MTT assay showed remarkable 
cytotoxicity against MCF-7 cell. This flavonoid 
could be developed as an alternative chemopreven-
tive agent, however further research should be pur-
sued.
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